Last reviewed · How we verify

Aripiprazole and sertraline

Otsuka Pharmaceutical Co., Ltd. · Phase 1 active Small molecule

Aripiprazole and sertraline is a Small molecule drug developed by Otsuka Pharmaceutical Co., Ltd.. It is currently in Phase 1 development.

At a glance

Generic nameAripiprazole and sertraline
SponsorOtsuka Pharmaceutical Co., Ltd.
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Aripiprazole and sertraline

What is Aripiprazole and sertraline?

Aripiprazole and sertraline is a Small molecule drug developed by Otsuka Pharmaceutical Co., Ltd..

Who makes Aripiprazole and sertraline?

Aripiprazole and sertraline is developed by Otsuka Pharmaceutical Co., Ltd. (see full Otsuka Pharmaceutical Co., Ltd. pipeline at /company/otsuka).

What development phase is Aripiprazole and sertraline in?

Aripiprazole and sertraline is in Phase 1.

Related